b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31298476</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>09</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>08</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1612-1880</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>16</Volume>\n                    <Issue>9</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Sep</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Chemistry &amp; biodiversity</Title>\n                <ISOAbbreviation>Chem. Biodivers.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Cytotoxic Spliceostatin Analogs from Pseudomonas sp.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e1900266</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cbdv.201900266</ELocationID>\n            <Abstract>\n                <AbstractText>Two new spliceostatin analogs, designed as spliceostatins J and K (1 and 2), were isolated and identified from the culture of Pseudomonas sp., along with two known ones, FR901464 (3) and spliceostatin E (4). Their structures were elucidated by detailed interpretation of their spectroscopic data, especially 2D-NMR and HR-ESI-MS. Spliceostatin J (1) represented the first example of spliceostatins bearing an unusual hexahydrofuro[3,4-b]furan moiety. Biological assay showed all the isolated compounds except 1 displayed potent cytotoxic activities against two cancer cell lines (MDA-MB-231 and A-549). Structure-activity-relationship studies revealed that the tetrahydropyran ring in spliceostatin analogs was necessary for their bioactive retention.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 Wiley-VHCA AG, Zurich, Switzerland.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zhao</LastName>\n                    <ForeName>Hong</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>First Clinical Medicine College, Zhejiang Chinese Medical University, Hangzhou, 310006, P. R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Bei</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>First Clinical Medicine College, Zhejiang Chinese Medical University, Hangzhou, 310006, P. R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ma</LastName>\n                    <ForeName>Lie-Feng</ForeName>\n                    <Initials>LF</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, P. R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shi</LastName>\n                    <ForeName>Lin-Mei</ForeName>\n                    <Initials>LM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Lishui Technology College, Lishui, 323000, P. R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhan</LastName>\n                    <ForeName>Zha-Jun</ForeName>\n                    <Initials>ZJ</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7865-5435</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, P. R. China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>81703368</GrantID>\n                    <Agency>National Natural Science Foundation of China</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>81872777</GrantID>\n                    <Agency>National Natural Science Foundation of China</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>LY16H300003</GrantID>\n                    <Agency>Natural Science Foundation of Zhejiang Province</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>2016RC04</GrantID>\n                    <Agency>Science and Technology Plan Project of Lishui</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>08</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Chem Biodivers</MedlineTA>\n            <NlmUniqueID>101197449</NlmUniqueID>\n            <ISSNLinking>1612-1872</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C104486">FR 901464</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D005663">Furans</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007783">Lactones</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011714">Pyrans</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011753">Pyrones</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D013141">Spiro Compounds</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000596810">spliceostatin E</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004354" MajorTopicYN="N">Drug Screening Assays, Antitumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005663" MajorTopicYN="N">Furans</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007783" MajorTopicYN="N">Lactones</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011549" MajorTopicYN="N">Pseudomonas</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011714" MajorTopicYN="N">Pyrans</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011753" MajorTopicYN="N">Pyrones</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013141" MajorTopicYN="N">Spiro Compounds</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Pseudomonas</Keyword>\n            <Keyword MajorTopicYN="N">bacteria</Keyword>\n            <Keyword MajorTopicYN="N">biological activity</Keyword>\n            <Keyword MajorTopicYN="N">cytotoxicity</Keyword>\n            <Keyword MajorTopicYN="N">spliceostatin</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>19</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31298476</ArticleId>\n            <ArticleId IdType="doi">10.1002/cbdv.201900266</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>F. Zhang, H.-Y. He, M.-C. Tang, Y.-M. Tang, Q. Zhou. G.-L. Tang, \xe2\x80\x98Cloning and elucidation of the FR901464 gene cluster revealing a complex acyltransferase-less polyketide synthase using glycerate as starter units\xe2\x80\x99, J. Am. Chem. 2011, 133, 2452-2462.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>H.-Y. He, M.-C. Tang, F. Zhang, G.-L. Tang, \xe2\x80\x98cis-Double bond formation by thioesterase and transfer by ketosynthase in FR901464 biosynthesis\xe2\x80\x99, J. Am. Chem. Soc. 2014, 136, 4488-4491.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>A. S. Eust\xc3\xa1quio, J. E. Janso, A. S. Ratnayake, C. J. O\'Donnell, F. E. Koehn, \xe2\x80\x98Spliceostatin hemiketal biosynthesis in Burkholderia spp. is catalyzed by an iron/\xce\xb1-ketoglutarate-dependent dioxygenase\xe2\x80\x99, Proc. Natl. Acad. Sci. USA 2014, 111, E3376-E3385.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>H. Nakajima, B. Sato, T. Fujita, S. Takase, H. Terano, M. Okuhara, \xe2\x80\x98Antitumor substances, FR901463, FR901464 and FR901465. I. taxonomy, fermentation, isolation, physico-chemical properties and biological activities\xe2\x80\x99, J. Antibiot. 1996, 49, 1196-1203.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>H. Nakajima, Y. Hori, H. Terano, M. Okuhara, T. Manda, S. Matsumoto, K. Shimomura, \xe2\x80\x98New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action\xe2\x80\x99, J. Antibiot. 1996, 49, 1204-1211.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>H. Nakajima, S. Takase, H. Terano, H. Tanaka, \xe2\x80\x98Antitumor substances, FR901463, FR901464 and FR901465. III. Structures of FR901463, FR901464 and FR901465\xe2\x80\x99, J. Antibiotica 1997, 50, 96-99.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>X.-Y. Liu, S. Biswas, G.-L. Tang, Y.-Q. Cheng, \xe2\x80\x98Isolation and characterization of spliceostatin B, a new analog of FR901464, from Pseudomonas sp. No. 2663\xe2\x80\x99, J. Antibiotica 2013, 66, 555-558.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>X.-Y. Liu, S. Biswas, M. G. Berg, C. M. Antapli, F. Xie, Q. Wang, M.-C. Tang, G.-L. Tang, L.-X. Zhang, G. Dreyfuss, Y.-Q. Cheng, \xe2\x80\x98Genomics-guided discovery of thailanstatins A, B, and C as premRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43\xe2\x80\x99, J. Nat. Prod. 2013, 76, 685-693.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>H.-Y. He, A. S. Ratnayake, J. E. Janso, M. He, H. Y. Yang, F. Loganzo, B. Shor, C. J. O\'Donnell, F. E. Koehn, \xe2\x80\x98Cytotoxic spliceostatins from Burkholderia sp. and their semisynthetic analogs\xe2\x80\x99, J. Nat. Prod. 2014, 77, 1864-1870.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Y. Zhao, J.-W. Zhao, C. Lu, H. Zhang, H. Qi, S.-W. Jiang, X.-W. Guo, J.-D. Wang, W.-S. Xiang, \xe2\x80\x98Two new spliceostatin analogs from the strain Pseudomonas sp. HS-NF-1408\xe2\x80\x99, J. Antibiot. 2018, 71, 667-671.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>D. Kaida, H. Motoyoshi, E. Tashiro, T. Nojima, M. Hagiwara, K. Ishigami, H. Watanabe, T. Kitahara, T. Yoshida, H. Nakajima, T. Tani, S. Horinouchi, M. Yoshida, \xe2\x80\x98Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA\xe2\x80\x99, Nat. Chem. Biol. 2007, 3, 576-583.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>C.-W. Lo, D. Kaida, S. Nishimura, A. Matsuyama, Y. Yashiroda, H. Taoka, K. Ishigami, H. Watanabe, H. Nakajima, T. Tani, S. Horinouchi, M. Yoshida, \xe2\x80\x98Inhibition of splicing and nuclear retention of pre-mRNA by spliceostatin A in fission yeast\xe2\x80\x99, Biochem. Biophys. Res. Commun. 2007, 364, 573-577.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>D. Pham, K. Koide, \xe2\x80\x98Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1\xe2\x80\x99, Nat. Prod. Rep. 2016, 33, 637-647.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>C. Lagisetti, A. Pourpak, T. Goronga, Q. Jiang, X. Cui, J. Hyle, J. M. Lahti, S. W. Morris, T. R. Webb, \xe2\x80\x98Synthetic mRNA splicing modulator compounds with in Vivo antitumor activity\xe2\x80\x99, J. Med. Chem. 2009, 52, 6979-6990.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>S. Osman, W. R. Waud, G. S. Gorman, B. W. Day, K. Koide, \xe2\x80\x98Evaluation of FR901464 analogs in\xe2\x80\x85vitro and in\xe2\x80\x85vivo\xe2\x80\x99, MedChemComm 2011, 2, 38-43.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>S. Osman, B. J. Albert, Y.-P. Wang, M.-S. Li, N. L. Czaicki, K. Koide, \xe2\x80\x98Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464\xe2\x80\x99, Chem. Eur. J. 2011, 17, 895-904.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>B. J. Albert, A. Sivaramakrishnan, T. Naka, N. L. Czaicki, K. Koide, \xe2\x80\x98Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analog\xe2\x80\x99, J. Am. Chem. Soc. 2007, 129, 2648-2659.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>B. J. Albert, P. A. McPherson, K. O\'Brien, N. L. Czaicki, V. DeStefino, S. Osman, M. Li, B. W. Day, P. J. Grabowski, M. J. Moore, A. Vogt, K. Koide, \xe2\x80\x98Meayamycin inhibits premRNA splicing and exhibits picomolar activity against multidrug resistant cells\xe2\x80\x99, Mol. Cancer Ther. 2009, 8, 2308-2318.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>L.-F. Ma, H. Xu, J.-D. Wang, X.-M. Tong, Z.-J. Zhan, Y.-M. Ying, J.-W. Wang, H. Zhang, W.-G. Shan, \xe2\x80\x98Three new eudesmane sesquiterpenoids and a new dimer from the aerial part of Salvia plebeia R. Br.\xe2\x80\x99, Phytochem. Lett. 2018, 25, 122-125.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>L.-F. Ma, P.-F. Wang, J.-D. Wang, X.-M. Tong, W.-G. Shan, H. Zhang, Z.-J. Zhan, \xe2\x80\x98New Eudesmane Sesquiterpenoids from Salvia plebeia R. Br.\xe2\x80\x99, Chem. Biodiversity 2017, 14, e1700127.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>H. Zhao, R. Wu, L.-F. Ma, L.-K. Wo, Y.-Y. Hu, C. Chen, Z.-J. Zhan, \xe2\x80\x98Aurovertin-Type Polyketides from Calcarisporium arbuscula with Potent Cytotoxic Activities against Triple-Negative Breast Cancer\xe2\x80\x99, Helv. Chim. Acta 2016, 99, 543-546.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Y.-M. Ying, C.-Y. Li, Y. Chen, J.-G. Xiang, L. Fang, J.-B. Yao, F.-S. Wang, R.-W. Wang, W.-G. Shan, Z.-J. Zhan, \xe2\x80\x98Lupane- and Friedelane-Type Triterpenoids from Celastrus stylosus\xe2\x80\x99, Chem. Biodiversity 2015, 12, 1222-1228.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Z.-J. Zhan, Y.-T. Wen, F.-Y. Ren, G.-W. Rao, W.-G. Shan, C.-P. Li, \xe2\x80\x98Diterpenoids and a Diarylheptanoid from Hedychium coronarium with Significant Anti-Angiogenic and Cytotoxic Activities\xe2\x80\x99, Chem. Biodiversity 2012, 9, 2754-2760.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Y.-M. Yu, J.-S. Yang, C.-Z. Peng, V. Caer, P.-Z. Cong, Z.-M. Zou, Y. Lu, S.-Y. Yang, Y.-C. Gu, \xe2\x80\x98Lactones from Angiopteris caudatiformis\xe2\x80\x99, J. Nat. Prod. 2009, 72, 921-924.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>S. Gr\xc3\xa9laud, J. Lusseau, Y. Landais, \xe2\x80\x98Acyl radical addition to activated olefins: a stereocontrolled route to polysubstituted tetrahydrofurans and lactones, and application to the total synthesis of (+)-No. 2106A\xe2\x80\x99, Eur. J. Org. Chem. 2017, 1323-1330.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Z.-B. Cheng, W.-W. Shao, Y.-N. Liu, Q. Liao, T.-T. Lin, X.-Y. Shen, S. Yin, \xe2\x80\x98Extracellular signal-regulated kinases (ERK) inhibitors from Aristolochia yunnanensis\xe2\x80\x99, J. Nat. Prod. 2013, 76, 664-671.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>S. R. Gollapudi, H. Telikepalu, H. B. Jampani, Y. W. Mirhom, S. D. Drake, K. R. Bhattiprolu, D. V. Velde, L. A. Mitscher, \xe2\x80\x98Alectosarmentin, a new antimicrobial dibenzofuranoid lactone from the lichen, Alectroria sarmentosa\xe2\x80\x99, J. Nat. Prod. 1994, 57, 934-938.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'